Introduction

o-Vanillin and its Schiff base compounds have strong antibacterial activities [1,2,3]. Compounds containing pyridine groups [4] and amides containing aromatic ring substituents have both better antibacterial activities [5], such as pyridine-2,6-dicarboxamide compounds, and their derivatives have also good antibacterial effect [6]. Bismuth is the only green heavy metal element in nature with relative cheap, low toxicity and low radioactivity. Organic bismuth compounds have been widely used in the field of medicine [7,8,9,10,11]. For example, bismuth subcitrate, bismuth salicylate, ranitidine bismuth citrate and other drugs, with antisecretory, cell protection and anti-Helicobacter pylori, are used to treat gastric and duodenal ulcers [12, 13]. In recent years, exploring the antibacterial and antitumor activity of organic bismuth compounds has become a research hot spot [14,15,16,17].

Schizosaccharomyces pombe (S. pombe) has become an ideal model organism for studying eukaryotic cells, because S. pombe have obvious mitotic cycle, similar to the human cell division process, and playing an important role in studying the mechanism of action of drugs [18]. The biological analysis of microcalorimetry is based on release of heat in cell metabolism. Various metabolic processes in living cells are accompanied by energy transfer and change of heat. The inhibition of cell metabolism by microcalorimetry is based on the interaction between inhibitors and cells, which changes the heat of cells production. The decrease in cell heat production reflects the inhibition of various biochemical reactions in the process of cellular metabolism. The increase in cell heat production reflects the vigorous process of cell metabolism, which is beneficial to the growth of cell metabolism. It has been proved that microcalorimetry may be the best way to measure cell metabolism because it reflects the sum of cellular metabolic processes and can directly determine the different sensitivity of various cells to their inhibitors [19, 20]. Microcalorimetry is a general, real-time, non-damage and highly sensitive method based on biothermokinetics. It has been gradually applied in the assay of biological activity in vitro. This method has significant advantages over traditional assay methods such as continuous dilution method and agar plate diffusion method [21, 22].

In this work, a new N-alkylation Schiff base was directly reacted by o-vanillin with electron-deficient pyridine-2,6-dicarboxamide using a novel solid-phase microwave green synthesis method, which required neither catalyst nor solvent. A new bismuth(III) complex was synthesized reacting of the ligand and BiCl3. The antibacterial activity of the ligand and its bismuth(III) complex on S. pombe was determined by microcalorimetry. The biothermokinetic equation was established according to the measured power–time curves. The quantitative relationships between the thermokinetic parameters such as the growth rate constant (k), generation time (tG) and inhibition ratio (I) and with the concentration of the ligand and its bismuth(III) complex were obtained. Furthermore, we further investigated the action target of bismuth(III) complex on BSA by the molecular docking simulation method. As a basic research, one of the purposes of this study is to explore the possibility of microcalorimetric method to predict and evaluate the bioactivity of drugs. On the other hand, it will provide a basis for further study of N-alkylation Schiff base and its bismuth compounds.

Experimental

Reagents

o-Vanillin (VAN) (C8H8O3, 99.0%), pyridine-2,6-dicarboxamide (PCA) (C7H7N3O2, 99.0%) and ethanol (EtOH, 99.5%) were purchased from the Sinopharm Chemical Reagent Co., Ltd. (Shanghai,China); dimethylsulfoxide (DMSO, > 99.5%) and N,N-dimethyl formamide (DMF, > 99.5%) were bought from Tianjin Guangfu Chemical Research Institute (Tianjin, China); bismuth chloride (BiCl3, 99%) was obtained from Tianjin Jingke Chemical Research Institutes (Tianjin, China). All other chemicals including sodium chloride (NaCl, 99.5%), silver nitrate (AgNO3, 99.8%) and ethylenediaminete traacetic acid (EDTA, 99.0%) were purchased from the Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China).

Cell lines and culture conditions

S.pombe (ACCC 20,047) was provided by Beijing Century Aoke Biological Technology Co., Ltd. YES medium (per dm3) consisted of yeast (5.000 g), glucose (30.000 g), L-leu (0.225 g), L-lys (0.225 g), L-his (0.225 g), adenine (0.225 g) and uracil (0.225 g). The inoculum medium was sterilized at 120 °C for 30 min in an autoclave. The water used in this work was double-distilled. All chemicals and reagents were used as received without further purification.

Instrumentation and measurement

Bioactivity was determined by a bio-microcalorimeter (TAM air 3116–2/3239, Switzerland); CY-CR100C-S vertical microwave microreactor (Hunan Changyi Microwave Technology Co., Ltd.) was used to assist the direct condensation N-alkylation reaction. Molecular weights of the ligand and its bismuth(III) complex were determined using a LCQ Fleet Ion Trap Mass Spectrometer (Thermo Fisher). FT-IR spectra (400–4000 cm−1) were measured using a Thermo Nicolet Avatar 360 Fourier transform IR spectrometer with a KBr pellet. 1HNMR spectra were recorded on a Bruker 400 MHz advance nuclear magnetic resonance spectrometer with DMSO-d6 as solvent and trimethylsilicane (TMS) as internal standard. The elemental analysis of C, H and N was carried out on a PerkinElmer 2400 elemental analyzer. The content of Bi3+ in bismuth(III) complex was determined by the EDTA titration and Optima 8300 ICP-OES, respectively. The content of Cl in bismuth(III) complex was determined by Mohr method. All absorption spectra were measured by a Hitachi U-3010 UV–Vis spectrophotometer. The purity of the ligand and its bismuth(III) complex was determined by L-7000 HPLC (Hitachi, Japan). Thermal properties of bismuth(III) complex were determined by a Shimadzu DTG-60 thermogravimetric/differential thermal analyzer (TG/DSC) in flowing air with a heating rate of 10 °C min−1 between 25 °C and 1450 °C. The molar conductance was determined by a DDS-12DW conductivity meter (Shanghai Lida Instrument Factory, China).

Synthesis of the ligand

A mass of 4 mmol (about 0.6 g, slightly excess) of powdered VAN was placed in a conical bottle with grinding plug. The conical bottle was placed in a water bath with constant temperature of 60 °C to make VAN melt into bright yellow liquid. Then, a mass of 2 mmol (about 0.3 g) of powdered PCA was added to the melted VAN liquid and stirred evenly, the mixture was yellow and sticky liquid. Subsequently, the mixture was irradiated in a 700 W microwave reactor for 5 min. After taking out and cooling to room temperature, the black-brown solid was ground into powder. After that, DMF was slowly dropped into the beaker containing black powder and stir until the powder was completely dissolved. Bright yellow solid was precipitated out when slightly excess anhydrous ethanol was added into the above solution, and was left to settle for 3 h. Finally, the bright-yellow product was obtained by filtration and washed with a small amount of anhydrous ethanol several times. The product was put into a drying box at 100 °C for 24 h and kept until the mass of the product became constant. The yield was 79%, and the purity was 98.10%. The synthetic scheme of the ligand is depicted in Fig. 1.

Fig. 1
figure 1

Synthetic scheme of the ligand

Synthesis of bismuth(III) complex

A mass of 1 mmol of the ligand was placed into a three-neck flask, and then, 5 cm3 DMF was added with stirring to dissolve it completely (solution A). A mass of 1 mmol of BiCl3 (slightly excess) was placed into a conical bottle; added 5 cm3 of DMF by stir to dissolve it completely (solution B). At 60 °C, solution B was added slowly into solution A, and refluxed, heated and stirred for 8 h. As the reaction proceeded, the color of the mixture became brown–red, and an appropriate amount of anhydrous ethanol was added to precipitate the brown–red solid, which was left to settle for 12 h. The brown–red solid was obtained by filtration and washed with a small amount of anhydrous ethanol several times. The product was put in a drying box at 100 °C for 24 h and kept until its mass became constant. The yield of the product was 80%, and its purity was 99.15%. The synthetic scheme of bismuth(III) complex is depicted in Fig. 2.

Fig. 2
figure 2

Synthetic scheme of bismuth(III) complex

Determination of bioactivity of the ligand and its bismuth(III) complex on growth metabolism of S. pombe

The bioactivity of the ligand and its bismuth(III) complex on growth metabolism of S. pombe was evaluated using ampoule method on a bio-microcalorimeter at 32 °C. The principle and structure of the instrument were elucidated in literature [23]. Once the bio-microcalorimeter reached a stable baseline, 5 cm3 YES culture medium containing the suspensions of S. pombe at the cell density of 1 × 106 colony-forming units in each milliliter (CFU cm−3) was added to sterilized 20 cm3 glass ampoules. The ligand and its bismuth(III) complex were injected into the bacterial suspension at different concentrations. Then, all sealed ampoules were shaken up gently and put into the measuring channels. Before the power–time curves were recorded, there was about 30 min for pre-incubation. All signals reflecting thermokinetic information were collected by a computer in a real-time manner.

Interaction of bismuth(III) complex with BSA

To preliminarily reveal the action mechanism of bismuth(III) complex on S. pombe cells, the binding sites of bismuth(III) complex on BSA were investigated by molecular simulation docking using AutoDock Vina software. BSA proteins used for molecular docking were downloaded from PDB database (PDB ID: 4F5S) by MOE(version 2010) software, and to remove water and ligand molecules and retain a chain. Then, the amber 99 force field was added to the protein, and 3D protonation was performed. The structure of the bismuth(III) complex was constructed by Chemdraw software, and its energy optimization was carried out by MMFF94x force field in MOE. Molecular docking binding mode of bismuth(III) complex with BSA was studied by MOE docking. The possible binding sites were searched by Site Finder algorithm systematically in the BSA to find a total of 40 possible binding pockets. The 40 binding pockets were scored, and the firstly, 20 pockets were screened out as potential pockets for molecular docking; then, 20 docking conformations were selected in each potential pocket for scoring, and the conformation of highest scoring was selected as the best conformation for each pocket. Then, these 20 pockets were ranked according to the score of the best conformation in each pocket, and the highest scoring pocket might be the best binding site of bismuth(III) complex in BSA.

Results and discussion

Physical properties of the ligand and its bismuth(III)complex

The ligand and its bismuth(III) complex were bright yellow and brown–red powder, respectively. Both the ligand and its bismuth(III) complex were very easy to dissolve in DMF and DMSO, but difficult to dissolve in methanol, ethanol and acetone, as well as water. The molar conductivities of solution (0.0010 mol dm−3) of the ligand and its bismuth(III) complex were determined using DMSO as solvent to be 5.49 and 36.50 S cm2 mol−1 at 25 °C, respectively, which showed that they were all non-electrolytes. The melting point of the ligand and its bismuth(III) complex was measured to be 235 ± 1 °C and 264 ± 1 °C by using binocular stereo micro melting point instrument, respectively.

Elemental and chemical analysis

The measured values (theoretical value) for the elemental analysis of the ligand were as follows: C, 64.44% (64.77%); H, 5.27% (5.02%); N, 9.15% (9.11%). The chemical composition of the complex was determined by elemental analysis for C, H and N, by EDTA titration for Bi3+ and by AgNO3 titration for Cl. The found values (theoretical values) for the elemental analysis and chemical analysis of bismuth(III) complex were as follows: C, 42.25% (42.66%); H, 3.09% (3.01%); N, 6.12% (5.97%); Bi, 29.39% (29.69%); Cl, 5.13% (5.04%).

1HNMR and ESI–MS analysis

The 1HNMR (400 MHz, DMSO-d6) spectrum and ESI–MS of the ligand were as follows: 10.30(d, 2H, OH), 8.91(d, 2H, NH), 8.22–6.84(m, 9H, Ar–H), 3.74(d, 4H, CH), 3.37(s, 6H, OCH3). ESI–MS, (m/z): [M + H]+ = 437.2 (Calcd. M = 436.2).

The 1HNMR (400 MHz, DMSO-d6) spectrum and ESI–MS of bismuth(III) complex were as follows: 8.91 (d, 2H, NH), 8.22–7.75(m, 9H, Ar–H), 3.80(d, 4H, CH),3.40(s, 6H, OCH3). ESI–MS, (m/z): [M + H]+ = 679.4 and [M + Na]+ = 701.5 (Calcd. M = 678.4).

UV spectra

The UV spectra of the DMSO solution (0.0010 mol dm−3) of the ligand and its bismuth(III) complex were determined, which are shown in Fig. 3. It could be seen that the nπ* absorption band of the ligand at 340 nm was formed by the coupling of the solitary pair electrons on the p orbital of the nitrogen atom in the C-N–C group with the large π bond of the pyridine ring. Moreover, another strong absorption peak at 283 nm was formed by the large π–π* bond of benzene ring conjugation. A larger conjugated system was formed than the ligand when the ligand was coordinated with Bi3+ ions, π–π* absorption band red-shifts to 306 nm and n–π* absorption band blue-shifts to 323 nm and stronger. Finally, this two absorption bands were superimposed into a wide and strong absorption peak.

Fig.3
figure 3

UV spectra of the ligand and its bismuth(III)complex

IR spectra

The IR spectra of the ligand and its bismuth(III) complex are presented in Fig. 4. From Fig. 4, after the complex was formed, the sharp absorption peak of Ph-OH of the ligand at 3405 cm−1 was disappeared, which indicated that the phenolic hydroxyl group Ph-O was involved in the coordination. This result has been confirmed by 1HNMR of the ligand and its bismuth(III) complex. Moreover, compared with the ligand the absorption peak (N–H) at 3232 cm−1 red-shifted to 3307 cm−1, the two absorption peaks (C-N) at 1383 and 1269 cm−1 red-shifted to 1389 and 1274 cm−1, indicating that the C-N took part in coordination. The absorption peak of pyridine-N at 1494 cm−1 was split into bi-peak 1492 cm−1 and 1458 cm−1, indicated that pyridine-N was coordinated with bismuth ion. In low wavelength range, the absorption peaks (C-O) at 1079 cm−1 was blue-shifted to1074 cm−1, and single peak (C-N) at 618 cm−1 was split into bi-peak 660 cm−1 and 615 cm−1 compared with the ligand, indicated that the sign of O-Bi3+ and N-Bi3+ bond was formed, further confirming that N and O atoms were coordinated with Bi3+.

Fig. 4
figure 4

IR spectra of the ligand and its bismuth(III) complex

Thermal properties of bismuth(III) complex

The TG-DSC of the complex was determined in air atmosphere at a heating rate of 10 °C/min in the range 25 °C to 1450 °C, which is shown in Fig. 5. As shown in Fig. 5, there was no mass loss from 50 to 200 °C, which indicated that the complex has no crystal water. The thermal decomposition process of the complex was divided into two steps. In the first step, it had a strong endothermic peak in the range 230 °C to 380 °C with a mass loss of 50.1%, which was close to the theoretical value (49.7%) due to the loss of 1 mol of Cl and 2 mol of C8H9O2N (VAN is the main structure). In the second step, it had a weak endothermic peak in the range 380 °C to 516 °C with a mass loss of 20.2%, which corresponds to the loss of 1 mol of C7H3O2N (PCA is the main structure) (theoretical value is 19.6%) (The loss involves two processes. One is the carbon–nitrogen bond breaking, which involves endothermic process. The other is the bismuth–oxygen bond forming, which involves exothermic process. Bond formation and fracture occur almost simultaneously, and the corresponding endothermic and exothermic process offsets each other partially. Thus, it exhibits a weak endothermic peak.). The final product of complete decomposition of the complex was Bi2O3 by ICP analysis. The molecular formula of the complex is Bi(C23H21O6N3)Cl by experimental and theoretical calculated results, whose mechanism of thermal decomposition was as follows:

$${\text{Bi}}({\text{C}}_{23} {\text{H}}_{21} {\text{O}}_{6} {\text{N}}_{3} ){\text{Cl}}\mathop{\longrightarrow}\limits^{{230 - 380^{{\text{o}}} {\text{C}}}}{\text{Bi}}({\text{C}}_{7} {\text{H}}_{3} {\text{O}}_{2} {\text{N}}) \, \mathop{\longrightarrow}\limits^{{380 - 516^{{\text{o}}} {\text{C}}}}1/2{\text{Bi}}_{2} {\text{O}}_{3}$$
Fig.5
figure 5

TG-DSC diagram of bismuth(III) complex

It is worth mentioning that the melting point of bismuth (III) complex was measured to be 264 ± 1 °C by using binocular stereo micro melting point instrument, but on the DSC curve could not be observed any sign of melting. It may be that the melting temperature of the complex is very close to its decomposition temperature, resulting in the endothermic peak of melting and the endothermic peak of decomposition overlaps each other, so the endothermic peak of complex melting is not obvious on the curve.

To sum up, it was finally inferred that the compositions of the ligand and its bismuth(III) complex were C23H23N3O6 and Bi(C23H21O6N3)Cl, respectively. Their possible chemical structures are depicted in Fig. 6.

Fig. 6
figure 6

Chemical structure of the ligand (a) and its bismuth(III) complex (b)

Microcalorimetry

Power–time curves

When the suspensions of S. pombe are introduced into the ampoules with YES culture medium, the power–time curve of S. pombe growth of blank control is plotted in Fig. 7a. As depicted in Fig. 7a, the observable growth curve of S. pombe consisted of four phases [the lag phase (AB), the exponential phase (BC), the stationary phase (CD) and the decline phase (DE)]. As the suspensions of S. pombe are added to the ampoules with different concentrations of the ligand and its bismuth(III) complex, the shapes of Pt curves were also changed (Fig. 7b, c). The curves in Fig. 7 illustrated that the height, peak time and shape of each experimental group were obviously different from the blank control group.

Fig. 7
figure 7

Power–time curves of the growth of S. pombe affected by a blank control, b the ligand and c its bismuth(III) complex at 32 °C

Biothermokinetics

In the exponential growth phase, the biothermokinetic equation of growth metabolic of S. pombe could be established by simulating the exponential equation, as shown in Eq. 1 [24]:

$$n_{{\text{t}}} = n_{{0}} {\text{exp[}}k(t - t_{{0}} ){]}$$
(1)

where t0 was the initial time of logarithmic period, t was any time of logarithmic period. nt and n0 represented the bacterial number at time t and t0, respectively. If the power produced by every bacterium is w, then we can obtain the following equation

$$n_{{\text{t}}} w = n_{{0}} w{\text{exp[}}k(t - t_{{0}} ){]}$$
(2)

Making pt = ntw, p0 = n0 w, then Eq. (2) can change to

$$p_{{\text{t}}} = p_{{0}} {\text{exp[}}k(t - t_{{0}} ){]}$$
(3)

or

$$\ln p_{{\text{t}}} = \ln p_{{0}} - kt_{{0}} + kt$$

or

$$\ln p_{{\text{t}}} = A + kt$$
(4)

where pt was the power output at time t and k was growth rate constant for S. pombe at specified conditions. Then, lnPt against t was plotted and fitted linearly to obtain its linear equation. The growth rate constant k was obtained according to slope of linear equation. The values of k are listed in Table 1.

Table 1 Thermokinetic parameters of the growth of S. pombe treated by different concentrations of the ligand and its bismuth(III) complex at 32 °C

Quantitative relationship between k and c

The k values in Table 1 revealed that Schiff base and its bismuth(III) complex had both potent antibacterial activity against S. pombe and the complex displayed stronger inhibition than the ligand. The quantitative relationship between k and c is demonstrated in Fig. 8.

Fig. 8
figure 8

Relationships between the growth rate constant (k) of S. pombe and concentration (c) of the ligand and its bismuth(III) complex

The k of S. pombe decreased with the increasing concentration (c). This may be due to S. pombe cells being suppressed or killed by the tested drug, which reduces metabolic thermal power. The k-c equations could be described as below:

$$\begin{aligned} k_{{{\text{the}}\;{\text{ligand}}}} = & - 5.4 \times 10^{ - 4} + 6.0 \times 10^{ - 4} /[1 + e^{{625\left( {c - 0.00938} \right)}} ] \hfill \\ & (0.00\;{\text{mol}}\;{\text{dm}}^{ - 3} \le c \le 5.32 \times 10^{ - 3} {\text{mol}}\;{\text{dm}}^{ - 3} ) \hfill \\ \end{aligned}$$
(5)
$$\begin{aligned} k_{{\text{the complex}}} = & - 7.0 \times 10^{ - 4} + 9.0 \times 10^{ - 4} /[1 + e^{{1250\left( {c - 0.00243} \right)}} ] \hfill \\ & (0.00\;{\text{mol}}\;{\text{dm}}^{ - 3} \le c \le 2.42 \times 10^{ - 3} {\text{mol}}\;{\text{dm}}^{ - 3} ) \hfill \\ \end{aligned}$$
(6)

Quantitative relationship between t G and c

Because the biothermokinetic Eq. (4) was very similar to the indefinite integral relation of rate equation of the first order reaction, the mathematical expression of generation time (tG) of S. pombe could be defined by simulating the relationship between the half-life of the first-order reaction and the rate constant of the reaction (see Eq. 7):

$$t_{G} = \ln 2/k$$
(7)

where tG was the generation time and k was growth rate constant of S. pombe. The tG of S. pombe were calculated at different concentration of the ligand and its bismuth(III) complex. As summarized in Table 1, the tG was longer than that of blank control. With increasing concentration of the ligand and its bismuth(III) complex, the tG prolonged. It is because that, after the treatment with the tested drugs, there was a partial inhibition of S. pombe and other survivor maintained growth and metabolized at a lower rate.

The tG-c curves were drawn for the generation time (tG) and the concentration(c) of the ligand and its bismuth(III) complex (Fig. 9).

Fig. 9
figure 9

Relationships between the generation time (tG) of S. pombe and concentration (c) of the ligand and its bismuth(III) complex

The correlation between tG and c could be formulated according to following equations:

$$\begin{aligned} t_{{{\text{G}}({\text{the ligand}})}} =& 11333.274 + 5.367 \times 10^{ - 2} /[4(c - 0.00597)^{2} + 2.60 \times 10^{ - 7} ] \hfill \\ & (0.00\;{\text{mol}}\;{\text{dm}}^{ - 3} \le c \le 5.32 \times 10^{ - 3} {\text{mol}}\;{\text{dm}}^{ - 3} ) \hfill \\ \end{aligned}$$
(8)
$$\begin{aligned} t_{{{\text{G}}({\text{the complex}})}} = & 10058.944 + 2.721 \times 10^{ - 2} /[4(c - 0.0026)^{2} + 1.37 \times 10^{ - 6} ] \hfill \\ & (0.00\;{\text{mol}}\;{\text{dm}}^{ - 3} \le c \le 2.42 \times 10^{ - 3} {\text{mol}}\;{\text{dm}}^{ - 3} ) \hfill \\ \end{aligned}$$
(9)

Inhibition ratio (I) and half inhibition concentration (IC 50)

The inhibition ratio (I) of the growth metabolism of S. pombe treated by the ligand and its bismuth(III) complex could be defined as follows:

$$I = (k_{0} - k_{c} )/k_{0} \times 100\%$$
(10)

where k0 and kc are the growth rate constants of S. pombe without and with the tested drugs, respectively. When the inhibition ratio (I) was 50%, the corresponding concentration of inhibitor was called as the half inhibition concentration IC50. The values of I and IC50 are shown in Table 1.

The inhibition ratio (I) and concentration (c) of the ligand and its bismuth(III) complex are plotted in Fig. 10.

Fig. 10
figure 10

Relationships between inhibition ratio (I) of S. pombe and concentrations (c) of the ligand and its bismuth(III) complex

From the data in Table 1 and the plot in Fig. 10, we could see that the inhibition ratio (I) was both increased with the increasing of concentration (c) of the ligand and its bismuth(III) complex, indicated that the growth of S. pombe was both inhibited by two tested drugs and the inhibitory effect of the complex was stronger than that of the ligand. The quantitative relationship between inhibition ratio (I) and concentration (c) by nonlinear fitting could be described in Eqs. (11) and (12):

$$\begin{aligned} I_{{({\text{the ligand}})}} =& 2.75 \times 10^{ - 3} /[4(c - 0.00811)^{2} + 4.37 \times 10^{ - 6} ] - 6.7686 \hfill \\ & (0.00\;{\text{mol}}\;{\text{dm}}^{ - 3} \le c \le 5.32 \times 10^{ - 3} {\text{mol}}\;{\text{dm}}^{ - 3} ) \hfill \\ \end{aligned}$$
(11)
$$\begin{aligned} I_{{({\text{the complex}})}} =& 5.41 \times 10^{ - 4} /[4(c - 0.00281)^{2} + 6.45 \times 10^{ - 6} ] - 14.4142 \hfill \\ & (0.00\;{\text{mol}}\;{\text{dm}}^{ - 3} \le c \le 2.42 \times 10^{ - 3} {\text{mol}}\;{\text{dm}}^{ - 3} ) \hfill \\ \end{aligned}$$
(12)

Meanwhile, the half inhibition concentration (IC50) of the ligand and its bismuth(III) complex was obtained to be 4.63 × 10–3 mol dm−3 and 2.10 × 10–3 mol dm−3, respectively. The results have shown that the bioactivity of the complex was greater than that of the ligand. Therefore, we believed that the bioactivity of the complex was not only related to the structure of the ligand, but more important depended on the property of bismuth(III) ion.

Action target of bismuth(III) complex on bovine serum albumin (BSA)

Action target of BSA interaction with bismuth(III) complex was studied by molecular docking as shown in Fig. 11.

Fig. 11
figure 11

a The docking conformation of bismuth(III) complex-BSA complex with lowest energy and b the amino acid residues of surround bismuth(III) complex

Figure 11a illustrates that bismuth(III) complex bound at the hydrophobic cavity of the substructure domain IIB of BSA and was the best conformation of bismuth (III) complex–BSA complex with lowest energy. Figure 11b shows that the amino acid residues interacting with bismuth(III) complex were: Leu115, Pro117, Leu122, Tyr160, Ile181, Met184, Lys136, Val188, Arg185, Ile141, Tyr137, Glu140 and Lys114. The Trp137 and Arg185 interacted with bismuth(III) complex through hydrogen bonds, while the remaining amino acid residues interacted with the complex via hydrophobic and van der Waals; these were consistent with the literatures [25, 26].

Conclusions

In this work, we described the synthesis of a new N-alkylation Schiff base and its bismuth(III) complex for the first time, and their compositions and structures were characterized using various physicochemical detection methods. Moreover, the biothermokinetic and bioactivity of Schiff base and its bismuth(III) complex on growth metabolism of S. pombe were studied. Some thermokinetic parameters (k, tG and I) and their quantitative relationship with concentration were investigated. Finding that two compounds had both inhibition effects on S. pombe cells and the inhibitory effect of the complex was stronger than that of the ligand. Besides the action target of bismuth(III) complex on BSA was investigated by molecular docking simulation method, it was found that they bind mainly to amino residues in the subdomain IIB of the hydrophobic cavity of BSA.